Do you take time to read the risk warnings on drug websites before you take the drug?
Mariea Hoy, an advertising professor at UT, has studied that question and determined that no, you probably don’t.
Last month, Hoy presented her findings in Washington, DC at a Federal Trade Commission workshop titled “Putting Disclosures to Test.”
Hoy and former UT faculty member Abbey Levenshus, who now teaches at Butler University in Indiana, conducted the research, and their findings were recently published in the Journal of Risk Research.
“We looked at whether consumers seek out, notice, and read risk disclosures on a branded drug website,” Hoy said.
See the full story in the Tennessee Today.